Janney Montgomery Scott LLC Bristol Myers Squibb CO Transaction History

Janney Montgomery Scott LLC

  • $32.8 Billion
  • Q2 2024

A detailed history of Janney Montgomery Scott LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 714,616 shares of BMY stock, worth $35.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
714,616
Previous 939,078 23.9%
Holding current value
$35.3 Million
Previous $50.9 Million 41.72%
% of portfolio
0.09%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$40.25 - $52.99 $9.03 Million - $11.9 Million
-224,462 Reduced 23.9%
714,616 $29.7 Million
Q1 2024

May 01, 2024
BUY
$47.98 - $54.4 $4.21 Million - $4.77 Million
87,690 Added 10.3%
939,078 $50.9 Million
Q4 2023

Feb 07, 2024
BUY
$48.48 - $57.85 $4.69 Million - $5.6 Million
96,733 Added 12.82%
851,388 $43.7 Million
Q3 2023

Nov 08, 2023
SELL
$57.89 - $64.73 $518,810 - $580,110
-8,962 Reduced 1.17%
754,655 $43.8 Million
Q2 2023

Jul 26, 2023
BUY
$63.71 - $70.74 $470,307 - $522,202
7,382 Added 0.98%
763,617 $48.8 Million
Q1 2023

Apr 28, 2023
BUY
$65.71 - $74.53 $1.09 Million - $1.23 Million
16,564 Added 2.24%
756,235 $52.4 Million
Q4 2022

Feb 01, 2023
SELL
$68.48 - $81.09 $1.02 Million - $1.2 Million
-14,829 Reduced 1.97%
739,671 $53.2 Million
Q3 2022

Oct 25, 2022
SELL
$0.13 - $76.84 $135 - $80,374
-1,046 Reduced 0.14%
754,500 $53.6 Million
Q2 2022

Aug 03, 2022
SELL
$72.62 - $79.98 $6.97 Million - $7.68 Million
-95,994 Reduced 11.27%
755,546 $59.3 Million
Q1 2022

May 04, 2022
BUY
$61.48 - $73.72 $1.13 Million - $1.36 Million
18,391 Added 2.21%
851,540 $62.2 Million
Q4 2021

Jan 27, 2022
SELL
$53.63 - $62.52 $521,283 - $607,694
-9,720 Reduced 1.15%
833,149 $51.9 Million
Q3 2021

Oct 29, 2021
SELL
$59.17 - $69.31 $4,141 - $4,851
-70 Reduced 0.01%
842,869 $49.9 Million
Q2 2021

Jul 26, 2021
SELL
$61.91 - $67.42 $2 Million - $2.18 Million
-32,287 Reduced 3.69%
842,939 $56.3 Million
Q1 2021

Apr 27, 2021
BUY
$59.34 - $66.74 $820,968 - $923,347
13,835 Added 1.61%
875,226 $55.3 Million
Q4 2020

Jan 25, 2021
BUY
$57.74 - $65.43 $1.79 Million - $2.03 Million
30,950 Added 3.73%
861,391 $53.4 Million
Q3 2020

Nov 06, 2020
BUY
$57.43 - $63.64 $1.55 Million - $1.71 Million
26,942 Added 3.35%
830,441 $50.1 Million
Q2 2020

Jul 23, 2020
BUY
$54.82 - $64.09 $2.05 Million - $2.39 Million
37,320 Added 4.87%
803,499 $47.2 Million
Q1 2020

Apr 30, 2020
BUY
$46.4 - $67.43 $132,054 - $191,905
2,846 Added 0.37%
766,179 $42.7 Million
Q4 2019

Jan 21, 2020
BUY
$49.21 - $64.19 $2.57 Million - $3.35 Million
52,200 Added 7.34%
763,333 $49 Million
Q3 2019

Oct 29, 2019
BUY
$42.77 - $50.71 $3.32 Million - $3.94 Million
77,690 Added 12.26%
711,133 $36.1 Million
Q2 2019

Jul 29, 2019
SELL
$44.62 - $49.34 $3.73 Million - $4.12 Million
-83,495 Reduced 11.65%
633,443 $28.7 Million
Q1 2019

Apr 30, 2019
BUY
$45.12 - $53.8 $6.24 Million - $7.44 Million
138,363 Added 23.91%
716,938 $34.2 Million
Q4 2018

Feb 01, 2019
SELL
$48.76 - $63.23 $102,152 - $132,466
-2,095 Reduced 0.36%
578,575 $30.1 Million
Q3 2018

Nov 05, 2018
SELL
$55.19 - $62.25 $554,549 - $625,488
-10,048 Reduced 1.7%
580,670 $36 Million
Q2 2018

Jul 24, 2018
SELL
$50.53 - $62.98 $269,628 - $336,061
-5,336 Reduced 0.9%
590,718 $32.7 Million
Q1 2018

Apr 19, 2018
SELL
$59.92 - $68.98 $424,533 - $488,723
-7,085 Reduced 1.17%
596,054 $37.7 Million
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $925,353 - $1.01 Million
-15,438 Reduced 2.5%
603,139 $37 Million
Q3 2017

Nov 15, 2017
BUY
$55.23 - $63.74 $34.2 Million - $39.4 Million
618,577
618,577 $39.4 Million

Others Institutions Holding BMY

# of Institutions
2,400
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $105B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email